Device Week, 4 February 2021 – SPACs In Medtech; Manus’ Parkinson’s Pen; TAVR During COVID

This week’s podcast includes an update on the growing trend of “blank check” companies taking medtech companies public, a spotlight on Manus’ pen that can diagnose Parkinson’s disease, and a look at how pandemic is impacting valve replacements. Medtech Insight articles addressing topics in this episode: Blank Check Companies’ Hunt For Innovative Medtech Start-Ups To Heat Up Further, Experts Predict http://bit.ly/2YIxqIn Start-Up Spotlight: Manus Neurodynamica Hopes To Write The End Of Traditional Parkinson’s Diagnosis http://bit.ly/3aA7VOP Edwards Keeps TAVR Going During COVID-19 Surge http://bit.ly/3cIyJiK